Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.

Persons of blood group O are at increased risk of developing cholera gravis. In a randomized, placebo-controlled, double-blind safety-immunogenicity trial of live oral cholera vaccine CVD 103-HgR in 5- to 9-year-old Chilean children, vibriocidal antibody seroconversion (74% overall) did not differ b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lagos, R, Avendaño, A, Prado, V, Horwitz, I, Wasserman, S, Losonsky, G, Cryz, S, Kaper, J B, Levine, M M
Formato: Artigo
Idioma:Inglês
Publicado: 1995
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC173056/
https://ncbi.nlm.nih.gov/pubmed/7822046
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares